Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01197443 · ClinicalTrials.gov registry record · NA

Parents as the Agent of Change for Childhood Obesity

A NA study, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
152
Enrollment target

NCT01197443: Completed NA study, sponsored by University of California, San Diego.

NCT01197443 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01197443, a NA study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
152 participants
Enrollment target

Study Summary

The overall intent of this study is to explore a promising mode for delivering treatment for childhood obesity via parent education only, and to evaluate the cost effectiveness compared to the current gold standard treatment of parent-and-child dual education.

Primary Outcome

The primary hypothesis is that the parent-only treatment will produce a decrease in the target child's weight (BMI for age percentile/BMI\_Z) that is not inferior to the parent + child treatment immediately following treatment.

Interventions

  • BEHAVIORAL Parent-only Group
  • BEHAVIORAL Parent + Child Group

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2010-11
Est. Completion 2015-07
Phase NA
University of California, San Diego

775 total trials

What the finished NCT01197443 record still lists

NCT01197443 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Parent-only Group is the first listed.

NCT01197443 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01197443 about?

NCT01197443 is a clinical study titled "Parents as the Agent of Change for Childhood Obesity". The overall intent of this study is to explore a promising mode for delivering treatment for childhood obesity via parent education only, and to evaluate the cost effectiveness compared to the current gold standard treatment of parent-and-child dual education.

What is the current status of trial NCT01197443?

This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2010-11. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01197443?

The interventions under investigation include: Parent-only Group (BEHAVIORAL), Parent + Child Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01197443?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01197443's enrollment target sits among peer trials

152 658th of 2000 higher than 1,340 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03328078 · 152 participants · Phase 1

    CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • NCT04458532 · 152 participants · NA

    Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

  • NCT04858334 · 152 participants · Phase 2

    APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

  • NCT04993859 · 152 participants

    Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01197443, the US trial registry maintained by the National Library of Medicine. NCT01197443 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.